All In MedTech

FDA Clearance Tracker · P070008-S075

Pacemaker/ICD/CRT non implanted components; PSW 1602.U; HMSC 3.34.0

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 3, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 3, 2017

Approved

Time to decision

279 days

Received Jul 28, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P070008-S075
Device name
Pacemaker/ICD/CRT non implanted components; PSW 1602.U; HMSC 3.34.0
Applicant location
Lake Oswego, OR
Received
Jul 28, 2016
Decided
May 3, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P070008

Device type

Device class
Class III

Every decision under product code NKE

FDA's approval statement

As written in FDA's record.

Approval for the Ilivia, Intica and Inlexa families of ICDs and CRT-Ds, BS IS4 Blind Plug, as well as associated software updates PSW 1602.U and HMSC 3.34.0.

Source documents

Other decisions for Biotronik, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.